MORE than $200 million of infrastructure projects committed to as part of the 2017-18 South Australian Budget were last week considered by the Parliamentary Public Works Committee.
The submission includes key infrastructure projects including the $31.4 million relocation of Adelaide metropolitan rail Operations Control Centre from its existing premises near SAMHRI to Dry Creek, the $16.4 million Port Adelaide Spur Line and the $174.3 million Oaklands Crossing Grade Separation project.
The new Port Adelaide Spur Line will see train services reinstated back to the centre of Port Adelaide for the first time in almost 30 years. The new one-kilometre line will link the Port's commercial centre and the Dock One residential precinct to the Adelaide CBD.
The project includes the following works:
- New dual mainline connections from the Outer Harbor Line to the Port Spur and upgrade of the track and supporting infrastructure on the spur line;
- New railway signalling system to control the junction and spur line, including train control system modifications;
- A new Port Adelaide Railway Station and integration of the station with the local urban precinct; and
- Provision of a mainline connection to the National Railway Museum.
To the south of Adelaide, updated designs have been released for the Oaklands Crossing Grade Separation project showing the rail line to be constructed under Morphett Road. The project also includes a new Oaklands Park Railway Station and grade separation of the Marino Rocks Greenway pedestrian and cycling shared use path at Morphett Road.
Other projects considered by the Committee include the relocation of the Adelaide metropolitan rail operations control centre to the Dry Creek depot, which will allow the existing North Terrace control centre to be demolished and the site to be made available for development of a new medical research facility, SAHMRI 2.
The SAHMRI 2 building will include the only Proton Therapy Unit in the Southern Hemisphere and will expand SAHMRI's capacity to conduct ground-breaking research, and dramatically increase Australian patients' access to the best cancer care.